Skip to content

Author

P. Nayak

We have 9 of 91 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Sirtuin 1-microRNA regulatory networks in liver diseases: Mechanistic convergence, cellular senescence, and translational implications.

Metabolic dysfunction-associated steatotic liver disease, hepatotoxicity, liver fibrosis, and hepatocellular carcinoma are stages of chronic liver injury that occur in the setting of complex interactions of the various factors, including metabolic dysregulation, inflammation, oxidative stress, and cellular senescence....

Amr A. El-Sehrawy, Safa H. Radhie, Mirza R. Baig et al. · 0 citations
Review Sep 2026

SLC7A11 in liver tissue homeostasis and disease: Cellular mechanisms linking ferroptosis, redox regulation, and hepatic cell survival.

Liver diseases involve major disturbances in iron metabolism, redox homeostasis, and lipid peroxidation; therefore, ferroptosis is considered as an important link between cellular stress and liver damage/progression. This article describes solute carrier family 7 member 11 (SLC7A11), the functional subunit of the cysti...

J. Gupta, Musaab Hamid Farhan, A. Smerat et al. · 0 citations
Review Sep 2026

Mitochondria-Centered Metabolic Microdomains: Regulatory Roles in Synaptic Plasticity and Circuit Homeostasis.

The metabolism of neuronal activity is highly localized and cannot be sustained by cell-wide distribution of energy. Neurons and glia organize metabolic enzymes, mitochondria, lipid droplets, and endoplasmic reticulum (ER) contacts into spatially localized microdomains that dynamically couple energy generation to synap...

S. Mohammad, A. K. Kareem, M. Rekha et al. · 0 citations
Review Sep 2026

NRF2-Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic Opportunities.

The molecular mechanisms by which NRF2 regulates ferroptosis, including KEAP1-NRF2 signaling, metabolic rewiring, iron homeostasis, lipid remodeling, and crosstalk with p53 and other stress-response pathways are summarized.

S. Mohammad, A. Vasudevan, Samreet Raizal Rodrigues et al. · 0 citations
Review Open access Sep 2026

Targeting the Immunosuppressive Microenvironment in Colorectal Cancer: Pharmacological and Nanomedicine Strategies

The fundamental immunosuppressive interactions within the TME are discussed and subsequently it is examined how these agents enhance immune responses by reprogramming stromal and immune cells, as well as their secreted mediators within the TIME.

Qamar Abuhassan, Usamah Sayed, Pareshkumar N. Patel et al. · 0 citations
Review Open access Jul 2026

New insights into the role of TWIST1 in breast cancer progression and metastasis.

Increasing clinical evidence indicates that elevated TWIST1 expression is associated with poor clinical outcomes, higher metastatic burden, and reduced treatment efficacy, emphasizing its importance as a prognostic biomarker and a potential therapeutic target in breast cancer management.

K. Saleh, R. S., P. Nayak et al. · 0 citations
Review Open access Sep 2026

Somatic Mosaicism of the Brain: The Functional Implications of Post‐Zygotic Mutations to Neural Circuits

It is concluded that understanding the brain as a dynamic mosaic of billions of distinct genomes—rather than a single‐genome organ—is essential for accurate disease modelling, diagnostics and the development of targeted therapies.

Maher Abdulrazzaq Al-Hakeem, Y. Q. Almajidi, S. Alshkarchy et al. · 0 citations
Review Open access Aug 2026

Tumor‐Associated Macrophages in the Chemoresistant Microenvironment of Gastric Cancer: Key Mechanisms and Intercellular Crosstalk

Current evidence on TAM‐driven chemoresistance in GC is synthesized, highlighting the molecular interplay between TAMs, tumor cells, and stromal components and underscores the potential of TAM‐centric therapies to overcome resistance and improve clinical outcomes.

S. Abdul-Rahman, Abdulkareem Shareef, S. Jyothi et al. · 0 citations
Review Open access Jul 2026

Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches

This review synthesizes available evidence indicating that several KIFs, specifically KIF4A, KIF14, KIF20A, and KIFC1, function as key oncogenic regulators and represent important prognostic biomarkers and therapeutic targets in bladder cancer.

Usamah Sayed, Noor Mazin Basheer, M. H. et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.